As of Jan 20
| +0.10 / +0.17%|
The 16 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 64.00, with a high estimate of 77.00 and a low estimate of 50.00. The median estimate represents a +5.96% increase from the last price of 60.40.
The current consensus among 21 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.